Re-expression of miR-146a in pancreatic cancer cells led to the inhibition of both EGFR and NF-kB signaling; this effect is paralleled by a reduced invasion capacity of these cancer cells [36]. The gene discussed is EGFR; the disease is familial pancreatic carcinoma.